It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Details
Title
Author Correction: The promise(s) of mesenchymal stem cell therapy in averting preclinical diabetes: lessons from in vivo and in vitro model systems
Author
Nagasuryaprasad, Kotikalapudi 1 ; Sampath Samuel Joshua Pragasam 1 ; Sukesh Narayan Sinha 2 ; Bhonde, R 3 ; Nemani Harishankar 4 ; Mungamuri, Sathish Kumar 2 ; Venkatesan Vijayalakshmi 1
1 ICMR-National Institute of Nutrition, Division of Cell and Molecular Biology, Hyderabad, India (GRID:grid.419610.b) (ISNI:0000 0004 0496 9898)
2 ICMR-National Institute of Nutrition, Division of Food Safety, Hyderabad, India (GRID:grid.419610.b) (ISNI:0000 0004 0496 9898)
3 Manipal Institute of Regenerative Medicine, Department of Regenerative Medicine, Bangalore, India (GRID:grid.411639.8) (ISNI:0000 0001 0571 5193); Dr. D. Y. Patil Vidyapeeth, Pune, India (GRID:grid.411639.8)
4 ICMR-National Institute of Nutrition, Division of Animal Facility, Hyderabad, India (GRID:grid.419610.b) (ISNI:0000 0004 0496 9898)
1 ICMR-National Institute of Nutrition, Division of Cell and Molecular Biology, Hyderabad, India (GRID:grid.419610.b) (ISNI:0000 0004 0496 9898)
2 ICMR-National Institute of Nutrition, Division of Food Safety, Hyderabad, India (GRID:grid.419610.b) (ISNI:0000 0004 0496 9898)
3 Manipal Institute of Regenerative Medicine, Department of Regenerative Medicine, Bangalore, India (GRID:grid.411639.8) (ISNI:0000 0001 0571 5193); Dr. D. Y. Patil Vidyapeeth, Pune, India (GRID:grid.411639.8)
4 ICMR-National Institute of Nutrition, Division of Animal Facility, Hyderabad, India (GRID:grid.419610.b) (ISNI:0000 0004 0496 9898)
Publication year
2021
Publication date
2021
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2576853407
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.